Keele Research Repository

Article

Marijan, S, Mastelić, A, Markotić, A, Režić-Mužinić, N, Vučenović, N, Barker, D, Pilkington, LI, Reynisson, J ORCID: https://orcid.org/0000-0003-4174-9512 and Čulić, VČ (2021) Thieno[2,3-b]Pyridine Derivative Targets Epithelial, Mesenchymal and Hybrid CD15s+ Breast Cancer Cells. Medicines, 8 (7).

Marijan, S, Markotić, A, Mastelić, A, Režić-Mužinić, N, Pilkington, LI, Reynisson, J ORCID: https://orcid.org/0000-0003-4174-9512 and Čulić, VČ (2020) Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment. Scientific Reports, 10 (1). 11876 - ?.

Mastelić, A, Čikeš Čulić, V, Režić Mužinić, N, Vuica-Ross, M, Barker, D, Leung, EY, Reynisson, J ORCID: https://orcid.org/0000-0003-4174-9512 and Markotić, A (2017) Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-b]pyridine anticancer compound. Drug Design Development and Therapy, 11. 759 - 769.